UBS analyst Timothy Arcuri reiterated a Buy rating and $185.00 price target on NVIDIA (NASDAQ: NVDA).

The analyst commented, "NVDA announced the H20 will now require a license for shipment to China and other D5 countries (e.g. Russia and other US arms-embargo countries) and the company is also taking a $5.5B reserve. Based on our discussions, this is effectively a ban. While clearly reducing NVDA’s ability to beat and raise, this may be a clearing event for the stock if in exchange for committing to build $500B of AI infrastructure in the US over the next 4yrs, NVDA used this as concession to effectively kill the AI Diffusion Rule. While we are making no changes to our current estimates, fully stripping H20 out of our numbers would drive ~$0.20 EPS impact."

For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.

Shares of NVIDIA closed at $112.20 yesterday.